Healthy volunteers help compare two versions of a common arthritis drug
NCT ID NCT07147257
First seen Jan 11, 2026 · Last updated Jun 19, 2026 · Updated 23 times
Summary
This study tested whether a new biosimilar drug called CHS-1420 works similarly to the approved drug Humira (adalimumab) in the body. It involved 238 healthy Chinese adults who received a single injection of either drug. The goal was to compare how the drugs are absorbed and processed, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ethics Committee of Hopeshine-Minsheng Hospital of Xinzheng
Zhengzhou, China
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.